Valuation: Agilent Technologies, Inc.

Market Cap 42.22B 36.59B 34.25B 31.25B 58.81B 4,027B 59.8B 402B 157B 2,016B 159B 155B 6,724B P/E 2026 *
29.1x
P/E 2027 * 25.5x
Enterprise Value 43.21B 37.45B 35.06B 31.99B 60.19B 4,122B 61.21B 411B 161B 2,063B 162B 159B 6,882B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.28x
Free-Float
99.81%
Yield 2026 *
0.69%
Yield 2027 * 0.73%
07-23 Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
06-25 Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group MT
1 day+0.52%
1 week+7.39%
Current month+8.04%
1 month+11.32%
3 months+34.12%
6 months+15.97%
Current year+9.86%
1 week 139.29
Extreme 139.29
150.24
1 month 125
Extreme 125
150.24
Current year 108.35
Extreme 108.35
150.24
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
2/27/26 Tax

Chief Executive Officer

279 0.0001%
2/27/26 Tax

Executive/Senior Manager

89 0.0000%
2/27/26 Tax

Executive/Senior Manager

124 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%+7.39%+30.98%+17.84% 42.22B
+0.89%+7.13%+30.84%+11.26% 224B
-0.92%+6.50%+3.84%-18.78% 146B
+2.00%+8.95%-14.97%+31.77% 142B
+1.45%+4.28%-50.18%+0.31% 74.19B
+1.77%+4.53%+19.83%+17.94% 53.99B
+1.07%+1.51%-13.73%-16.11% 50.85B
+0.78%+4.78%+48.59%+42.29% 40.75B
-0.26%+3.54%-0.34%+1.62% 32.86B
+2.18%+0.76%-20.92%+25.28% 32.43B
Average +0.87%+220.33%+3.40%+11.34% 83.86B
Weighted average by Cap. +0.81%+309.24%+5.47%+9.31%

Financials

2026 *2027 *
Net sales 7.45B 6.45B 6.04B 5.51B 10.38B 710B 10.55B 70.85B 27.76B 356B 27.97B 27.36B 1,186B 7.9B 6.85B 6.41B 5.85B 11B 753B 11.19B 75.15B 29.44B 377B 29.66B 29.01B 1,258B
Net income 1.47B 1.27B 1.19B 1.08B 2.04B 140B 2.08B 13.94B 5.46B 69.97B 5.5B 5.38B 233B 1.63B 1.42B 1.33B 1.21B 2.28B 156B 2.32B 15.55B 6.09B 78.04B 6.14B 6B 260B
Net Debt 992M 859M 805M 734M 1.38B 94.58B 1.4B 9.43B 3.7B 47.34B 3.72B 3.64B 158B -486M -421M -394M -360M -677M -46.33B -688M -4.62B -1.81B -23.19B -1.82B -1.78B -77.36B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-08-11 US$149.49 +0.52% 1,199,335
26-08-10 US$148.72 +1.88% 1,751,943
26-08-07 US$145.97 +3.28% 1,525,223
26-08-06 US$141.34 +0.16% 1,160,420
26-08-05 US$141.11 +1.37% 1,266,395
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
149.49USD
Average target price
159.32USD
Spread / Average Target
+6.57%

Quarterly revenue - Rate of surprise